Graft trussing and suspension construct
US-2024358496-A1 · Oct 31, 2024 · US
US10653514B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10653514-B2 |
| Application number | US-201715466299-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 22, 2017 |
| Priority date | Mar 8, 2011 |
| Publication date | May 19, 2020 |
| Grant date | May 19, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.
Opening claim text (preview).
That which is claimed: 1. A method of making a medical ribbon, comprising: providing a plurality of fibers, wherein the plurality of fibers are continuous length cross-linked collagen fibers; forming the plurality of fibers into yarns; providing at least one suture; providing the yarns as warp yarns and one or more weft yarns; and weaving the warp yarns and the one or more weft yarns together to form a ribbon body with a length while crossing the one or more weft yarns over a top of the at least one suture at intervals along the length of the ribbon body to attach the at least one suture to the ribbon body, wherein the at least one suture has at least one tail end that extends a distance of at least about 1 inch off at least one end of the ribbon body, wherein some of the plurality of fibers are cross-linked with a first agent and some of the plurality of fibers are cross-linked with a second agent that is different than the first agent. 2. The method of claim 1 , wherein the weaving step is carried out by attaching a single suture as the at least one suture to the ribbon body so that the single suture resides in a substantially straight line proximate a longitudinally extending centerline of the ribbon body, and wherein the single suture is formed of a different material than the plurality of fibers of the yarns. 3. The method of claim 1 , wherein the ribbon body comprises first and second long sides laterally spaced apart across a width of the ribbon body, wherein the providing the at least one suture is carried out to provide a plurality of sutures, and wherein the weaving step is carried out to attach the plurality of sutures to the ribbon body so that at least one suture of the plurality of sutures resides in a substantially straight line proximate the first long side of the ribbon body and at least one suture of the plurality of sutures resides in a substantially straight line proximate the second long side of the ribbon body. 4. The method of claim 1 , wherein the ribbon body comprises a perimeter with first and second long sides that are laterally spaced apart across a width of the ribbon body, wherein the providing the at least one suture is carried out to provide at least four sutures, and wherein the weaving step attaches at least two of the at least four sutures to be parallel and adjacent each of the first and second long sides of the ribbon body. 5. The method of claim 1 , wherein the weaving step is carried out to have the one or more weft yarns hold the at least one suture at discrete repeating segments along the length of the ribbon body. 6. The method of claim 1 , wherein the plurality of fibers comprise NDGA-polymerized collagen fibers. 7. The method of claim 1 , wherein the first and second agents provide some of the plurality of fibers with a different fiber tensile strength and a different intrabody degradation rate than others of the plurality of fibers. 8. The method of claim 7 , wherein the first agent is NDGA and the second agent is 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), and wherein the fibers cross-linked with EDC degrade faster than the fibers cross-linked with NDGA. 9. The method of claim 1 , wherein the at least one suture is defined by a plurality of long warp yarns with a length that is at least about 50% greater than others of the warp yarns in the ribbon body, wherein the plurality of long warp yarns are woven medially to be proximate a longitudinally extending centerline of the ribbon body, and wherein the plurality of long warp yarns extend a distance off each opposing end of the ribbon body forming two opposing tail ends as the at least one tail end. 10. The method of claim 1 , wherein the at least one suture comprises at least four separate sutures, wherein the at least four separate sutures include two parallel sutures attached to and extending along the length on one side of a longitudinally extending centerline of the ribbon body and the at least four separate sutures further include two parallel sutures attached to and extending along the length on an opposing side of the longitudinally extending centerline of the ribbon body. 11. The method of claim 1 , wherein the at least one suture comprises at least one nordihydroguaiaretic acid (NDGA) treated or at least one carbodiimide cross-linked collagen fiber. 12. The method of claim 1 , wherein the at least one suture comprises by a plurality of yarns comprising cross-linked synthetic collagen fibers, wherein the at least one suture extends only longitudinally along the length of the ribbon body and has a length sufficient to extend outwardly therefrom to define tail ends as the at least one tail end, and wherein the tail ends have a length in a range of about 2 inches to about 15 inches. 13. The method of claim 1 , wherein the plurality of fibers comprise carbodiimide cross-linked collagen fibers. 14. The method of claim 1 , wherein the at least one suture comprises a plurality of elongate synthetic collagen fibers. 15. The method of claim 1 , wherein some of the plurality of fibers forming one or more of the warp yarns are cross-linked with the first agent while others of the plurality of fibers forming the one or more warp yarns are cross-linked with the second agent. 16. The method of claim 1 , wherein the plurality of fibers forming one or more of the warp yarns are cross-linked with the first agent while the plurality of fibers forming another one or more of the warp yarns are cross-linked with the second agent. 17. A method of making a medical ribbon, comprising: providing a plurality of yarns comprising fibers, wherein the fibers are continuous length cross-linked collagen fibers, wherein the provided plurality of yarns are provided as warp yarns and one or more weft yarns; providing at least one suture; and weaving the warp yarns and the one or more weft yarns together to form a ribbon body with a length while crossing the one or more weft yarns over a top of the at least one suture at intervals along the length of the ribbon body to attach the at least one suture to the ribbon body so that the at least one suture has at least one tail end that extends a distance of at least about 1 inch off at least one end of the ribbon body, wherein the ribbon body has first and second primary surfaces and a perimeter with first and second long sides and first and second short sides, wherein the at least one suture extends in a straight linear orientation along the length of the ribbon body, wherein the at least one suture extends a length beyond both the first and second short sides of the ribbon body forming two tail ends as the at least one tail end, wherein the at least one suture is held under the one or more weft yarns with the at least one suture visible on only one of the first primary surface or the second primary surface of the ribbon body, wherein the one or more weft yarn terminates at the first and second short sides of the ribbon body, and wherein the at least one suture is spaced laterally inward from an outer edge of the first and second long sides of the ribbon body and extends out from the first and second short sides of the ribbon body while other adjacent warp yarns closer to the outer edge of the first and second long sides of the ribbon body terminate at the first and second short sides of the ribbon body. 18. A method of making a medical ribbon, comprising: providing a plurality of warp yarns having a first length, each warp yarn comprising a plurality of synthetic collagen fibers; providing a plurality of long warp yarns having a second length
Monocomponent artificial filaments or the like of proteins; Manufacture thereof · CPC title
of animal origin, e.g. catgut, collagen · CPC title
pharmaceutically effective · CPC title
Small thickness fabric, e.g. ribbons, tapes or straps · CPC title
composite · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.